ShreeOswal Seeds & Chemicals Ltd. (OSWALSEEDS) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): N/A
• Revenue Growth: -9.87%
• EPS Growth: N/A
• Country: IN
• Employees: 31
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Agricultural Inputs
• EPS (TTM): -0.35
• Shares Outstanding: 91,470,000
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: -0.16
• Price to Book (P/B): 2.47
• Price to Sales (P/S): 0.44
• P/FCF Ratio: 5.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 56 Neutral
• Price Target: ―

The score is driven primarily by improved financial performance in FY2025 (return to profitability, better leverage, and stronger cash generation), tempered by continued revenue decline, thin margins, and historically volatile cash flows. Technical and valuation views are neutral due to missing data.

Positive Factors

Profitability Improvement

The return to profitability in FY2025 indicates improved operational efficiency and cost management, which can enhance long-term financial stability.

Leverage Improvement

Improved leverage shows better financial health and reduced risk, providing more flexibility for future investments and growth.

Cash Flow Recovery

Strong cash flow recovery in FY2025 enhances liquidity and supports reinvestment in business operations, crucial for sustainable growth.

Negative Factors

Revenue Decline

Continued revenue decline suggests challenges in market demand or competitive positioning, potentially impacting long-term growth prospects.

Thin Margins

Thin margins indicate limited pricing power or high cost structure, which can constrain profitability and investment capacity over time.

Cash Flow Volatility

Volatile cash flows suggest inconsistent working capital management, which can affect liquidity and financial planning reliability.

ShreeOswal Seeds & Chemicals Ltd. Business Overview & Revenue Model

Company Description

ShreeOswal Seeds and Chemicals Limited produces, processes, and sells various agricultural seeds in India. Its product portfolio includes wheat seeds, soya bean seeds, mustard seeds, black gram, maize, mung, and isabgol. The company trades in agricultural produce. It is also involved in exporting activities. The company markets its products under the Oswal Gold, OSM-77, OSYM-55, Oswal Seeds, and 3 Star brand names. ShreeOswal Seeds and Chemicals Limited was founded in 2002 and is based in Neemuch, India.

How the Company Makes Money

ShreeOswal Seeds & Chemicals Ltd. generates revenue primarily through the sale of its seed products, which include hybrid and genetically modified seeds designed for various crops. Additionally, the company earns income from its agrochemical products, including fertilizers and pesticides, which are essential for modern farming practices. Key revenue streams also include partnerships with agricultural cooperatives and distribution agreements with retailers that expand the reach of its products. The company's focus on research and development leads to the introduction of new and improved seed varieties, driving sales and enhancing market share. Furthermore, seasonal demand fluctuations and government agricultural policies can significantly impact its earnings, as well as the adoption of sustainable farming practices that align with its product offerings.

ShreeOswal Seeds & Chemicals Ltd. Financial Statement Overview

Summary

FY2025 showed a meaningful recovery: profitability turned positive, leverage improved (debt-to-equity ~1.0 vs ~1.6), and cash flow rebounded strongly with positive operating cash flow and solid free cash flow. Offsetting this, revenue declined again and margins remain thin, with historical volatility in cash generation.

Income Statement

Profitability improved materially in FY2025 versus FY2024, with net income turning positive and operating profitability recovering (operating margin ~3.8% and net margin ~1.4% in FY2025 versus losses in FY2024). However, revenue declined again in FY2025 (about -6.7% year over year), and margins remain thin versus earlier years (FY2020–FY2022 showed stronger profitability). Overall: rebound in earnings quality, but growth is negative and profitability is still modest.

Balance Sheet

Leverage has moderated: debt-to-equity improved to ~1.0 in FY2025 from ~1.6 in FY2024, supported by higher equity and lower debt. Returns also recovered to a positive level (return on equity ~8.1% in FY2025 versus negative in FY2024). Offsetting this, leverage remains meaningful for the business, and the balance sheet saw notable volatility year to year, which increases risk if profitability softens again.

Cash Flow

Cash generation strengthened significantly in FY2025, with positive operating cash flow and strong free cash flow (~₹194m), reversing the negative operating and free cash flow in FY2024. Free cash flow was also well-supported relative to reported earnings (free cash flow close to net income in FY2025). The key weakness is historical volatility (negative operating cash flow in FY2021 and FY2024), suggesting working-capital swings and less consistent cash conversion across cycles.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.67B	2.46B	2.69B	2.72B	2.41B	1.61B
Gross Profit	290.06M	109.90M	65.12M	174.77M	144.21M	110.11M
EBITDA	230.41M	98.74M	8.07M	119.67M	105.25M	79.85M
Net Income	135.25M	35.29M	-41.61M	57.06M	54.36M	36.51M
Balance Sheet
Total Assets	0.00	1.05B	1.24B	1.28B	1.20B	926.90M
Cash, Cash Equivalents and Short-Term Investments	4.95M	2.40M	29.94M	49.54M	16.52M	7.68M
Total Debt	0.00	419.25M	638.63M	410.31M	415.77M	431.12M
Total Liabilities	-437.28M	613.79M	838.58M	837.84M	811.79M	594.37M
Stockholders Equity	437.28M	437.28M	402.04M	443.65M	386.89M	332.54M
Cash Flow
Free Cash Flow	0.00	193.94M	-189.51M	102.64M	41.63M	-115.75M
Operating Cash Flow	0.00	199.66M	-153.27M	118.85M	50.46M	-108.30M
Investing Cash Flow	0.00	-7.67M	-35.00M	-20.84M	21.09M	-3.79M
Financing Cash Flow	0.00	-260.92M	168.66M	-64.98M	-62.47M	104.73M

ShreeOswal Seeds & Chemicals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NATHBIOGEN	63 Neutral	₹2.76B	6.49	―	1.26%	18.68%	16.47%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
NOVAAGRI	58 Neutral	₹3.13B	11.50	―	―	13.15%	-20.51%
OSWALSEEDS	56 Neutral	―	―	―	―	-9.87%	―
LOVABLE	43 Neutral	₹1.10B	361.74	―	―	-2.52%	―